Literature DB >> 30324438

Generation of Functional Retinal Pigment Epithelium from Human Induced Pluripotent Stem Cells.

Caroline Brandl1,2,3.   

Abstract

The availability of otherwise not readily accessible intraocular cells via induced pluripotent stem cell (iPSC) technology offers great potential for disease modelling, drug screening, and cell-based transplantation therapy in degenerative ocular disorders. Direct differentiation of iPSCs into retinal pigment epithelium (RPE) is particularly straightforward, and iPSC-derived RPE cell cultures have been demonstrated to yield pure populations of functional cells that display many features of native RPE. Here, I describe a protocol for the generation of iPSC-derived RPE monolayer, their propagation, and cryostorage. A reliable monitoring for functional cell differentiation is achieved by measuring transepithelial resistance.

Entities:  

Keywords:  Activin A; Cell differentiation; Cell polarization; Induced pluripotent stem cells (iPSCs); Monolayer; Nicotinamide; Retinal pigment epithelium (RPE); Transepithelial resistance

Mesh:

Year:  2019        PMID: 30324438     DOI: 10.1007/978-1-4939-8669-9_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

Review 1.  Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration.

Authors:  Samaneh Dehghan; Reza Mirshahi; Alireza Shoae-Hassani; Masood Naseripour
Journal:  Stem Cell Res Ther       Date:  2022-05-26       Impact factor: 8.079

2.  Impaired ABCA1/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration.

Authors:  Federica Storti; Katrin Klee; Vyara Todorova; Regula Steiner; Alaa Othman; Saskia van der Velde-Visser; Marijana Samardzija; Isabelle Meneau; Maya Barben; Duygu Karademir; Valda Pauzuolyte; Sanford L Boye; Frank Blaser; Christoph Ullmer; Joshua L Dunaief; Thorsten Hornemann; Lucia Rohrer; Anneke den Hollander; Arnold von Eckardstein; Jürgen Fingerle; Cyrille Maugeais; Christian Grimm
Journal:  Elife       Date:  2019-03-13       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.